Additionally, a loss of TGF-β in the epithelial cells in CRC leads to a non-specific inflammatory response that promotes tumor progression [19], suggesting a significant role for TGF-β in directing an appropriate immune response in the TME. This evidence concerns the gene TGFB1 and neoplasm.